Mymetics Corporation (OTCQB: MYMX). We develop next-generation of prophylactic vaccines for infectious and life disabling diseases based on virosomes, lipid-based carriers containing functional fusion viral proteins and natural membrane proteins and specifically designed antigens.

Location
Additional address info
  • Biopole - Batiment Lysine
Canton
Facts & figures
  • Type of organization
    Public company
  • Year of foundation
    2000
  • Number of employees in Switzerland
    1-9

You may also be interested in